Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Citado por Google
- Similares en SciELO
- Similares en Google
Compartir
Medicas UIS
versión impresa ISSN 0121-0319
Resumen
MENDEZ-FANDINO, Yardany Rafael et al. Pituitary macroadenoma relapse after standard treatment. Medicas UIS [online]. 2017, vol.30, n.2, pp.89-93. ISSN 0121-0319. https://doi.org/10.18273/revmed.v30n2-2017010.
Introduction:
acromegaly is a disease of long evolution and multisystemic involvement, caused by an increased release of growth hormone after the metaphyseal closure of long bones. Diagnosis is often difficult and usually occurs between the fifth and sixth decade of life. The treatment is based on surgical resection, chemotherapy and radiotherapy, as on endocrine control by drugs. The disease has a low recurrence rate of from 2 to 14%.
Case presentation:
a 67 year old female patient with a diagnosis of acromegaly 15 years ago, who, after being subjected to standard treatment, presents progressive and clinical manifestations compatible with an active pituitary function.
Conclusions:
the patient relapsed effect of the disease with persistency of the benign tumor, due to the discontinuation of treatment and insufficient monitoring of the case; therefore strict monitoring is essential in patients receiving pharmacological therapy and surgical management by the health team. MÉD.UIS. 2017;30(2):89-93.
Palabras clave : Acromegaly; Growth Hormone; Growth Hormone - Secreting Pituitary Adenoma..